Manda T - Search Results

1

Ponalrestat, an aldose reductase inhibitor, inhibits cachexia syndrome induced by colon26 adenocarcinoma in mice.

Kawamura I, Lacey E, Yamamoto N, Sakai F, Takeshita S, Inami M, Nishigaki F, Naoe Y, Tsujimoto S, Manda T, Shimomura K, Goto T. Kawamura I, et al. Among authors: manda t. Anticancer Res. 1999 Sep-Oct;19(5B):4105-11. Anticancer Res. 1999. PMID: 10628361

2

Role of tissue factor in the antitumor effect of recombinant human tumor necrosis factor-alpha in mice.

Nishigaki F, Miyayasu K, Tsujimoto S, Manda T, Shimomura K. Nishigaki F, et al. Among authors: manda t. Anticancer Res. 1994 Nov-Dec;14(6B):2573-6. Anticancer Res. 1994. PMID: 7872683

3

Effect of FR143430, a novel cytokine suppressive agent, on adenocarcinoma colon26-induced cachexia in mice.

Yamamoto N, Kawamura I, Nishigaki F, Tsujimoto S, Naoe Y, Inami M, Elizabeth L, Manda T, Shimomura K. Yamamoto N, et al. Among authors: manda t. Anticancer Res. 1998 Jan-Feb;18(1A):139-44. Anticancer Res. 1998. PMID: 9568068

4

Anti-cachectic effect of FK317, a novel anti-cancer agent, in colon26 and LX-1 models in mice.

Naoe Y, Kawamura I, Inami M, Matsumoto S, Nishigaki F, Tsujimoto S, Manda T, Shimomura K. Naoe Y, et al. Among authors: manda t. Jpn J Cancer Res. 1998 Dec;89(12):1318-25. doi: 10.1111/j.1349-7006.1998.tb00529.x. Jpn J Cancer Res. 1998. PMID: 10081493 Free PMC article.

5

Activation of lipoprotein lipase and inhibition of B16 melanoma-induced cachexia in mice by ponalrestat, an aldose reductase inhibitor.

Kawamura I, Yamamoto N, Sakai F, Yamazaki H, Naoe Y, Inami M, Manda T, Shimomura K. Kawamura I, et al. Among authors: manda t. Anticancer Res. 1999 Jan-Feb;19(1A):341-8. Anticancer Res. 1999. PMID: 10226565

6

Ponalrestat, an aldose reductase inhibitor, inhibits cachexia syndrome in nude mice bearing human melanomas G361 and SEKI.

Kawamura I, Lacey E, Inami M, Nishigaki F, Naoe Y, Tsujimoto S, Manda T, Goto T. Kawamura I, et al. Among authors: manda t. Anticancer Res. 1999 Sep-Oct;19(5B):4091-7. Anticancer Res. 1999. PMID: 10628359

7

Cachexia induction by EL-4 lymphoma in mice and possible involvement of impaired lipoprotein lipase activity.

Tsujimoto S, Kawamura I, Inami M, Lacey E, Nishigaki F, Naoe Y, Manda T, Goto T. Tsujimoto S, et al. Among authors: manda t. Anticancer Res. 2000 Sep-Oct;20(5A):3111-6. Anticancer Res. 2000. PMID: 11062730

8

Effects of FK317, a novel anti-cancer agent, on survival of mice bearing B16BL6 melanoma and Lewis lung carcinoma.

Inami M, Kawamura I, Tsujimoto S, Nishigaki F, Matsumoto S, Naoe Y, Sasakawa Y, Matsuo M, Manda T, Goto T. Inami M, et al. Among authors: manda t. Cancer Lett. 2002 Jul 8;181(1):39-45. doi: 10.1016/s0304-3835(02)00044-7. Cancer Lett. 2002. PMID: 12430177

9

FR177391, a new anti-hyperlipidemic agent from Serratia. II. Pharmacological activity of FR177391.

Inami M, Kawamura I, Tsujimoto S, Yasuno T, Lacey E, Hirosumi J, Takakura S, Nishigaki F, Naoe Y, Manda T, Mutoh S. Inami M, et al. Among authors: manda t. J Antibiot (Tokyo). 2005 Oct;58(10):640-7. doi: 10.1038/ja.2005.88. J Antibiot (Tokyo). 2005. PMID: 16392680

10

Antiestrogenic and antitumor effects of droloxifene in experimental breast carcinoma.

Kawamura I, Mizota T, Mukumoto S, Manda T, Masuda K, Nakamura T, Kubota H, Matsumoto S, Nishigaki F, Shimomura K, et al. Kawamura I, et al. Among authors: manda t. Arzneimittelforschung. 1989 Aug;39(8):889-93. Arzneimittelforschung. 1989. PMID: 2818677

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

59 results

Search Page

Filters